共 50 条
- [1] A real-world study of adjuvant anti-PD-1 immunotherapy on stage III melanoma with BRAF, NRAS, and KIT mutations CANCER MEDICINE, 2023, 12 (15): : 15945 - 15954
- [4] Potential Reasons for Unresponsiveness to Anti-PD1 Immunotherapy in Young Patients with Advanced Melanoma LIFE-BASEL, 2021, 11 (12):
- [9] Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma Journal of Translational Medicine, 11
- [10] Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11